EMLAPATCH 5 POUR CENT, pansement adhésif cutané

pansement adhésif(ve) · cutanée

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formpansement adhésif(ve)

Routecutanée

Ingredient entries2

CountryFrance

Product identity

At a glance

Authorisation holder: ASPEN PHARMA TRADING (IRLANDE)
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 67458460

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for EMLAPATCH 5 POUR CENT, pansement adhésif cutané
Ingredient	Strength / reference	Source role
LIDOCAÏNEpansement	0,0250 g1 g d'émulsion pour un pansement adhésif cutané de 10 cm²	SAGroup 4
PRILOCAÏNEpansement	0,0250 g1 g d'émulsion pour un pansement adhésif cutané de 10 cm²	SAGroup 2

Pack references

Presentations (3)

1 boîte(s) de 20 pansement(s)

CIP13 3400930274057

Présentation active · Déclaration de commercialisation

1 boite(s) de 1 pansement(s)

CIP13 3400934000713

Présentation active · Déclaration de commercialisation

1 boite(s) de 20 pansement(s) ( abrogée le 17/05/2023)

CIP13 3400955887591

Présentation abrogée · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 67458460 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →